Persistent Impairment of Testicular Histology and Sperm Motility in Adult Rats Treated with Cisplatin at Peri-Puberty

Basic and Clinical Pharmacology and Toxicology

Volumn 109, Issue 2, 2011, Pages 85-96

  Favareto, Ana Paula Alves ^a   Fernandez, Carla Dal Bianco ^a   da Silva, Daniela Alessandra Fossato ^b   Anselmo Franci, Janete Aparecida ^c   Kempinas, Wilma De Grava ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GONADOTROPIN; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL VACUOLE; CONTROLLED STUDY; EJACULATION; EPIDIDYMIS; EXPERIMENTAL RAT; FEMALE; GERM CELL; GONADOTROPIN BLOOD LEVEL; HISTOPATHOLOGY; HYPOPHYSIS; KIDNEY MASS; LEYDIG CELL; LIVER WEIGHT; MALE; MALE FERTILITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROSTATE VENTRAL LOBE; PUBERTY; RAT; REPRODUCTIVE TOXICITY; SEMINAL VESICLE; SEMINIFEROUS TUBULE; SERTOLI CELL; SEXUAL BEHAVIOR; SPERMATOCYTE; SPERMATOGENESIS; SPERMATOGONIUM; SPERMATOZOON COUNT; SPERMATOZOON MOTILITY; SPERMATOZOON TAIL; TESTIS INJURY; TESTIS WEIGHT; TESTOSTERONE BLOOD LEVEL; TOXICITY TESTING; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BODY WEIGHT; CISPLATIN; FEMALE; FERTILITY; MALE; ORGAN SIZE; RATS; RATS, WISTAR; SEXUAL BEHAVIOR, ANIMAL; SEXUAL MATURATION; SPERM MOTILITY; SPERMATOGENESIS; TESTIS; TESTOSTERONE;

RATTUS;

EID: 79960262473     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2011.00688.x     Document Type: Article

References (65)

1. Clegg E. The age at which male rats become fertile. J Reprod Fertil 1960;1:119-20.
2. Ojeda SR, Andrews WW, Advis JP, White SS. Recent advances in the endocrinology of puberty. Endocr Rev 1980;1:228-57.
3. Golub MS, Collman GW, Foster PM, Kimmel CA, Rajpert-De Meyts E, Reiter EO et al. Public health implications of altered puberty timing. Pediatrics 2008;121:S218-30.
4. Robb GW, Amann RP, Killian GJ. Daily sperm production and epididymal sperm reserves of pubertal and adult rats. J Reprod Fertil 1978;54:103-7.
5. Zanato VF, Martins MP, Anselmo-Franci JA, Petenusci SO, Lamano-Carvalho TL. Sexual development of male Wistar rats. Braz J Med Biol Res 1994;27:1273-80.
6. a ed., Vol. 10. Pergamon, New York, 1997;5-61.
7. Fosså SD, Aass N, Kaalhus O. Testicular cancer in young Norwegians. J Surg Oncol 1988;39:43-63.
8. Segal R. Surveillance programs for stage I nonseminomatous germ cell tumors of the testis. Urol Oncol 2006;24:68-74.
9. Ahmad S. Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes. Chem Biodivers 2010;7:543-66.
10. Kobrinsky NL, Sposto R, Shah NR, Anderson JR, DeLaat C, Morse M et al. Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine and I-asparagine, maintenance chemotherapy, and transplantation: children's cancer group study CCG-5912. J Clin Oncol 2001;19:2390-6.
11. Oliver RT. Testicular cancer. Curr Opin Oncol 1996;8:252-8.
12. Forman D, Moller H. Testicular cancer. Cancer Surv 1994;19-20:323-41.
13. Einhorn LH, Foster RS. Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen? J Clin Oncol 2006;24:2597-8.
14. Cvitkovic E. Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treat Rev 1998;24:265-81.
15. Sawhney P, Giammona CJ, Meistrich ML, Richburg JH. Cisplatin-induced long-term failure of spermatogenesis in adult C57/BI/6J mice. J Androl 2005;26:136-45.
16. Ali BH, Al-Moundhri M, Tageldin M, Al Husseini IS, Mansour MA, Nemmar A et al. Ontogenic aspects of cisplatin-induced nephrotoxicity in rats. Food Chem Toxicol 2008;46:3355-9.
17. Lu QB, Kalantari S, Wang CR. Electron transfer reaction mechanism of cisplatin with DNA at the molecular level. Mol Pharm 2007;4:624-8.
18. Woźniak K, Błasiak J. Recognition and repair of DNA-cisplatin adducts. Acta Biochim Pol 2002;49:583-96.
19. Jung Y, Lippard SJ. Direct cellular responses to platinum-induced DNA damage. Chem Rev 2007;107:1387-407.
20. Sentürker S, Tschirret-Guth R, Morrow J, Levine R, Shacter E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch Biochem Biophys 2002;397:262-72.
21. Seaman F, Sawhney P, Giammona CJ, Richburg JH. Cisplatin-induced pulse of germ cell apoptosis precedes long-term elevated apoptotic rates in C57/BL/6 mouse testis. Apoptosis 2003;8:101-8.
22. Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 2000;41:405-11.
23. Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod Biol Endocrinol 2004;2:12.
24. Adler ID, el Tarras A. Clastogenic effects of cis-diamminedichloroplatinum II. Induction of chromosomal aberrations in primary spermatocytes and spermatogonial stem cells of mice. Mutat Res 1990;243:173-8.
25. Huang HF, Pogach LM, Nathan E, Giglio W. Acute and chronic effects of cisplatinum upon testicular function in the rat. J Androl 1990;11:436-45.
26. Kinkead T, Flores C, Carboni AA, Menon M, Seethalakshmi L. Short term effects of cis-platinum on male reproduction, fertility and pregnancy outcome. J Urol 1992;47:201-6.
27. Aydiner A, Aytekin Y, Topuz E. Effects of cisplatin on testicular tissue and the Leydig cell-pituitary axis. Oncology 1997;54:74-8.
28. Fiorini C, Tilloy-Ellul A, Chevalier S, Charuel C, Pointis G. Sertoli cell junctional proteins as early targets for different classes of reproductive toxicants. Reprod Toxicol 2004;18:413-21.
29. Seethalakshmi L, Flores C, Kinkead T, Carboni AA, Malhotra RK, Menon M. Effects of subchronic treatment with cis-platinum on testicular function, fertility, pregnancy outcome, and progeny. J Androl 1992;13:65-74.
30. Schrader M, Muller M, Straub B, Miller K. Testicular sperm extraction in azoospermic patients with gonadal germ cell tumors prior to chemotherapy - a new therapy option. Asian J Androl 2002;4:9-15.
31. Ishikawa T, Kamidono S, Fujisawa M. Fertility after high-dose chemotherapy for testicular cancer. Urology 2004;63:137-40.
32. Lange PH, Narayan P, Vogelzang NJ, Shafer RB, Kennedy BJ, Fraley EE. Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts. J Urol 1983;129:1131-5.
33. Howell SJ, Shalet SM. Testicular function following chemotherapy. Hum Reprod Update 2001;7:363-9.
34. Magelssen H, Brydøy M, Fosså SD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 2006;3:312-22.
35. Benedetto P. Chemotherapy of testis cancer. Cancer Control 1999;6:549-59.
36. Bieber AM, Marcon L, Hales BF, Robaire B. Effects of chemotherapeutic agents for testicular cancer on the male rat reproductive system, spermatozoa, and fertility. J Androl 2006;27:189-200.
37. Marcon L, Hales BF, Robaire B. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics, bleomycin, etoposide and cisplatin, on spermatogenesis, fertility, and progeny outcome in the male rat. J Androl 2008;29:408-17.
38. Bachmann K, Pardoe D, White D. Scaling basic toxicokinetic parameters from rat to man. Environ Health Perspect 1996;104:400-7.
39. Clermont Y. Kinetics of spermatogenesis in mammals: seminiferous epithelium cycle and spermatogonial renewal. Physiol Rev 1972;52:198-236.
40. França LR, Avelar GF, Almeida FF. Spermatogenesis and sperm transit through the epididymis in mammals with emphasis on pigs. Theriogenology 2005;63:300-18.
41. Fernandes GS, Arena AC, Fernandez CD, Mercadante A, Barbisan LF, Kempinas WG. Reproductive effects in male rats exposed to diuron. Reprod Toxicol 2007;23:106-12.
42. Seed J, Chapin RE, Clegg ED, Dostal LA, Foote RH, Hurtt ME et al. Methods for assessing sperm motility, morphology, and counts in the rat, rabbit, and dog: a consensus report. ILSI risk science institute expert working group on sperm evaluation. Reprod Toxicol 1996;10:237-44.
43. Filler R. Methods for evaluation of rat epididymal sperm morphology. In: Chapin RE, Heindel JH (eds). Methods in Toxicology: Male Reproductive Toxicology. Academic Press, San Diego, CA, 1993;334-43.
44. Leblond CP, Clemont Y. Spermatogenesis of rat, mouse, hamster and guinea pig as revealed by the periodic acid-fuchsin sulfureous acid technique. Am J Anat 1952;90:167-215.
45. Ahlenius S, Larsson K. Apomorphine and haloperidol-induced effects on male rat sexual behavior: no evidence for actions due to stimulation of central dopamine autoreceptors. Pharmacol Biochem Behav 1984;21:463-6.
46. Ågmo A. Male rat sexual behavior. Brain Res Protoc 1997;1:203-9.
47. Laskey JW, Klinefelter GR, Kelce WR, Ewing LL. Effects of ethane dimethanesulphonate (EDS) on adult and immature rabbit Leydig cells: comparison with EDS treated rat Leydig cells. Biol Reprod 1994;50:1151-60.
48. Tsavaris N, Kosmas C, Mylonakis N, Bacoyiannis C, Kalergis G, Vadiaka M et al. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy. Anticancer Res 2000;20:4777-83.
49. Martins NM, Santos NA, Curti C, Bianchi ML, Santos AC. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicol 2008;28:337-44.
50. Robaire B, Bayly SF. Testicular signaling: incoming and outgoing messages. Ann NY Acad Sci 1989;564:250-60.
51. Delbès G, Chan D, Pakarinen P, Trasler JM, Hales BF, Robaire B. Impact of the chemotherapy cocktail used to treat testicular cancer on the gene expression profile of germ cells from male Brown-Norway rats. Biol Reprod 2009;80:320-7.
52. Ateşşahin A, Şahna E, Türk G, Çeribasi AO, Yilmaz S, Yüce A et al. Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats. J Pineal Res 2006;41:21-7.
53. Ilbey YO, Ozbek E, Cekmen M, Simsek A, Otunctemur A, Somay A. Protective effect of curcumin in cisplatin-induced oxidative injury in rat testis: mitogen-activated protein kinase and nuclear factor-kappa B signaling pathways. Hum Reprod 2009;24:1717-25.
54. Marty MS, Chapin RE, Parks LG, Thorsrud BA. Development and maturation of the male reproductive system. Birth Defects Res B Dev Reprod Toxicol 2003;8:125-36.
55. Lirdi LC, Stumpp T, Sasso-Cerri E, Miraglia SM. Amifostine protective effect on cisplatin-treated rat testis. Anat Rec 2008;291:797-808.
56. Boekelheide K. Mechanisms of toxic damage to spermatogenesis. J Natl Cancer Inst Monogr 2005;34:6-8.
57. Pogach LM, Lee Y, Gould S, Giglio W, Meyenhofer M, Huang HFS. Characterization of cis-platinum induced Sertoli cell dysfunction in rodents. Toxicol Appl Pharmacol 1989;98:350-61.
58. Monsees TK, Franz M, Gebhardt S, Winterstein U, Schill WB, Hayatpour J. Sertoli cells as a target for reproductive hazards. Andrologia 2000;3:239-46.
59. Silici S, Ekmekcioglu O, Eraslan G, Demirtas A. Antioxidative effect of royal jelly in cisplatin-induced testes damage. Urology 2009;74:545-51.
60. Maines MD, Sluss PM, Iscan M. Cis-platinum mediated decrease in serum testosterone is associated with depression of luteinizing hormone receptors and cytochrome P-450 scc in rat testis. Endocrinology 1990;126:2398-406.
61. Maines MD, Mayer RD. Inhibition of testicular cytochrome P-450 dependent steroid biosynthesis by cis-platinum. J Biol Chem 1985;260:60-3.
62. Lee J, Richburg JH, Shipp EB, Meistrich ML, Boekelheide K. The Fas system, a regulator of testicular germ cell apoptosis, is differentially up-regulated in Sertoli cell versus germ cell injury of the testis. Endocrinology 1999;140:852-8.
63. Kim R, Tanabe K, Uchida Y, Emi M, Inoue H, Toge T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy. Cancer Chemother Pharmacol 2002;50:343-52.
64. Bragado P, Armesilla A, Silva A, Porras A. Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation. Apoptosis 2007;12:1733-42.
65. Weijl NI, Hopman GD, Wipkink-Bakker A, Lentjes EG, Berger HM, Cleton FJ et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998;9:1331-7.